ImmuneBiotech Expands Reach – Precision Probiotic GutMagnific® Now Available at Apoteket AB
Lund, Sweden – October 14, 2025
ImmuneBiotech Medical Sweden AB, a pioneer in precision probiotics and microbiome-based therapeutics, proudly announces the launch of its flagship product GutMagnific® at Apoteket AB, one of Sweden’s largest and most trusted pharmacy chains.
This marks a pivotal moment for ImmuneBiotech, as years of advanced research, product development, and real-world success now make GutMagnific® accessible nationwide through Apoteket’s online platform.
“This is a proud milestone for ImmuneBiotech and for me personally as a scientist and founder,” says Dr. Shahram Lavasani, CEO of ImmuneBiotech. “Apoteket’s decision to include GutMagnific® following their standard product review and approval process is an important recognition of the product’s quality and reliability. It reflects the dedication of our team and the growing trust among customers who value science-based health solutions.”
GutMagnific®, developed and produced in Sweden, now stands as one of the first Precision Probiotics available through Apoteket, representing an important step in making ImmuneBiotech’s Swedish innovation and scientific excellence more widely available to consumers across the country.
Consumers can now order GutMagnific® online nationwide through Apoteket’s webshop:
–Köp GutMagnific Mjölksyrabakterier, 30 st | Apoteket.se
Read the full pressrelease here
Learn more at www.ImmuneBiotech.com and www.GutMagnific.com
For further information, please contact:
Dr. Shahram Lavasani, CEO
ImmuneBiotech Medical Sweden AB
s.lavasani@immunebiotech.com
+46 700 90 8946